Allogene Therapeutics (ALLO) Fofon Wukun
Allogene Therapeutics
AI forecast: ALLO
AI akapichichin target price fowor next trading day, end of the week, ane end of the month. Change akapichichin fowor latest price. These are statistical estimates, not investment advice.
Price over the last 6 months
Premium e fannin na target-ka price ka AI an 1 raan, 1 uikku, 1 fawwun, fofon ane ekka fenn stock.
Unlock Premium🔒 Rekord faan faanik
Rekord fowkas past — fowkas past kato-in kato-in fowkas akis — akis akis Premium.
Unlock PremiumEttan An Company
Allogene Therapeutics, Inc. is a biotechnology company that develops T-cell therapies using allogeneic chimeric antigen receptors for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in California.